|Year : 2014 | Volume
| Issue : 1 | Page : 49-55
|Thyroid disorders associated with alopecia areata in Egyptian patients
Ola A Bakry1, Mohamed A Basha1, Maather K El Shafiee2, Wafaa A Shehata1
1 Department of Dermatology, Andrology and S.T.Ds, Faculty of Medicine, Menoufiya University, Menoufiya, Egypt
2 Department of Medical Biochemistry, Faculty of Medicine, Menoufiya University, Menoufiya, Egypt
|Date of Web Publication||23-Dec-2013|
Ola A Bakry
Department of Dermatology, Andrology and S.T.Ds, Faculty of Medicine, Menoufiya University, Menoufiya
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Context: Alopecia areata (AA) is a common form of localized, non-scarring hair loss. The etiopathogenesis of the disease is still unclear, but the role of autoimmunity is strongly suggested. AA is commonly associated with various autoimmune disorders; the most frequent among them is autoimmune thyroid disorders. Aim: To determine whether AA is associated with thyroid autoimmunity or thyroid function abnormalities in Egyptian patients. Materials and Methods: Fifty subjects with AA (37 males and 13 females) without clinical evidence of thyroid disorders were selected from Dermatology Outpatient Clinic, Menoufiya University Hospital, Menoufiya Governorate, Egypt, during the period from June 2009 to February 2010. They were divided into 3 groups according to severity of AA. Fifty age and sex-matched healthy volunteers (35 males and 15 females) were selected as a control group. Every case and control were subjected to history taking, complete general and dermatological examination. Venous blood samples were taken from cases and controls after taking their consents for measurement of thyroid stimulating hormone (TSH), free T3, freeT4 and detection of Anti-thyroglobulin Antibody (Tg-Ab) and Anti-thyroid Peroxidase Antibody (TPO-Ab). Results: Subclinical hypothyroidism was detected in 16% of cases. There were statistically significant differences between cases and controls regarding levels of TSH, free T3 and free T4. There were significant differences between cases and controls regarding the presence of Tg-Ab and TPO-Ab. Conclusions: Every patient with AA should be screened for thyroid functions and presence of thyroid autoantibodies even in absence of clinical manifestations suggestive of thyroid affection.
Keywords: Alopecia, autoimmunity, thyroid gland
|How to cite this article:|
Bakry OA, Basha MA, El Shafiee MK, Shehata WA. Thyroid disorders associated with alopecia areata in Egyptian patients. Indian J Dermatol 2014;59:49-55
|How to cite this URL:|
Bakry OA, Basha MA, El Shafiee MK, Shehata WA. Thyroid disorders associated with alopecia areata in Egyptian patients. Indian J Dermatol [serial online] 2014 [cited 2022 May 28];59:49-55. Available from: https://www.e-ijd.org/text.asp?2014/59/1/49/123494
What was known?
1. Hypothyroidism and thyroid autoimmunity are commonly associated with AA.
2. AA cases should be screened for thyroid dysfunction and thyroid autoimmunity even in the absence of clinical manifestations suggestive of these diseases.
| Introduction|| |
Alopecia areata is a common form of localized, non-scarring hair loss that occurs on any hair bearing skin. 
The etiopathogenesis of the disease is still unclear. It is suspected to be an autoimmune disease, having a genetic predisposition and being influenced by environmental and ethnic factors. ,
Autoimmunity is proposed to play a role in AA. The autoimmune process appears to be T-cell mediated although antibodies to anagen phase hair follicle structures are seen in about 90% of patients. , This autoimmune etiology has been proposed also on the basis of its association with various autoimmune diseases, including thyroid disorders, vitiligo, pernicious anemia, diabetes mellitus, lupus erythematosus, myasthenia gravis, lichen planus, atopic dermatitis, autoimmune polyendocrine syndrome type I and celiac disease. 
Thyroid disorders and vitiligo have the strongest association with AA.  Thyroid disorders that may be associated with AA include hypothyroidism, Hashimoto's thyroiditis, Graves' disease and simple goiter.  Among these, hypothyroidism was the most frequent association. 
The aim of this work was to determine whether AA is associated with thyroid autoimmunity or thyroid function abnormalities in Egyptian patients.
| Materials and Methods|| |
This study is a case-control study. It included 50 patients with AA without clinical evidence of thyroid disease (Group A) that were selected randomly from Dermatology outpatient clinic, Menoufiya University Hospital, Menoufiya Governorate, Egypt during the period from June 2009 to February 2010. Fifty age and Sex-matched healthy volunteers (Group B) were selected as a control group.
- All patients were subjected to:
- Thorough history taking regarding:
- Onset, course and duration of AA
- Past and family history of AA
- Dermatological examination with determination of site and number of lesions
Patients with any autoimmune disorders were excluded.
The severity of alopecia areata was graded according to Kavak et al.,  into:
- Mild: The presence of three or less patches of alopecia with a widest diameter of 3 cm or less, or the disease is limited to the eyelashes and eyebrows.
- Moderate: Existence of more than three patches of alopecia, or a patch greater than 3 cm at the widest diameter without alopecia totalis or alopecia universalis.
- Severe: Alopecia totalis or alopecia universalis.
- Snake shaped plaques extending to the scalp border or loss of hair in the shape of a wave at the circumference of head defined as ophiasis.
Patients included in this study fell in the 1 st three groups. None of the studied patients had ophiasis.
- Patients and controls were subjected to the following:
- Asking about symptoms of hyperthyroidism (anxiety, insomnia, weight loss, increased appetite, excessive sweating, heat intolerance, bowel and menstural changes, and eye changes as buffiness and double vision) and symptoms of hypothyroidism (easy fatigability, slow movement, weight gain, loss of appetite, skin dryness, cold intolerance, hoarseness of voice, and constipation). 
- Thorough eye examination (to detect staring look, exophthalmos, lid lag and external ocular movements) and thyroid examination (for size, consistency and pulsations).
- Blood sampling: A sample of 10 ml of venous blood was put into plain tube, left to stand for 10 mins, then centrifuged at 4000 rpm for 5 mins, and then the serum was used for determination of free T3, free T4, TSH, Tg-Ab and TPO-Ab.
- Free T3 and Free T4 were measured by IMMULITE 2000 which is a solid phase, enzyme labeled chemiluminescent competitive immunoassay. The solid phase is coated with monoclonal murine anti T3 antibody and monoclonal murine anti T4 antibody respectively. The liquid phase consists of alkaline phosphatase conjugated to T3 and to T4 respectively. 
- TSH was measured by IMMULITE 2000 which is a solid phase, Two-site chemiluminescent immunometric assay. 
- Tg-Ab and TPO-Ab were detected by enzyme linked immunosorbent assay, which is performed as a solid phase immunoassay. 
Results were collected, tabulated, and statistically analyzed by IBM personal computer and statistical package SPSS version 11. Data were statistically described in terms of range, mean ± standard deviation (±SD), frequencies (number of cases) and relative frequencies (percentages) when appropriate. Student's t-test was used for comparison between two groups having quantitative variables. Kruskal-Wallis test was used for comparison between three or more groups not normally distributed having quantitative variables. Chi-square test (χ2) was used to study association between two or more variables. Comparison of quantitative variables was done using Mann-Whitney test for independent samples. Sperman correlation coefficient (r) was used to detect association between qualitative and quantitative variables. A P < 0.05 was considered statistically significant. 
| Results|| |
This study is a case-control study. It included 100 subjects divided into two main groups:
It included 50 subjects with AA, 37 males and 13 females with age ranging from 6-50 years and with a mean ± SD age of of 26.38 ± 10.85 years.
This group was subdivided according to the severity of AA into three subgroups:
Group A1 (Mild): It included 30 subjects, 21 males (42%) and 9 (18%) females with mean ± SD age of 26.76 ± 11.55 years.
Group A2 (Moderate): It included 10 subjects, 9 males (18%) and 1 female (2%), with mean ± SD age of 25.50 ± 8.05 years.
Group A3 (Severe): It included 10 subjects, 7 males (14%) and 3 females (6%), with mean ± SD age of 26.10 ± 12.03 years.
[Table 1] shows the clinical data of studied patients.
It included 50 age and sex-matched healthy control subjects, 35 males and 15 females, with age ranging from 6-50 years and with a mean ± SD age of of 25.85 ± 11.60 years.
No evidence of thyroid disease was detected during local and general examination of patients and controls.
Among studied patients, hypothyrodism was found in eight cases (16%). Six cases of them (12%) were with severe AA and two cases (4%) were with moderate AA [Table 2].
|Table 2: Comparison of TSH, free T3 and free T4 among studied AA subgroups|
Click here to view
There were statistically significant differences between cases and controls regarding levels of TSH (P < 0.05), free T3 (P < 0.05) and free T4 (P < 0.001) [Table 3].
|Table 3: Statistical comparison between cases and control groups regarding TSH, free T3, free T4, Tg - Ab and TPO - Ab|
Click here to view
Tg-Ab were positive in 23 (46%) cases. Of these, eight cases were with subclinical hypothyroidism and the remaining 15 cases were euthyroid (data not shown). Tg-Ab were negative in all control subjects with statistically significant difference between cases and controls (P < 0.001) [Table 3].
TPO-Ab were positive in 24 (48%) cases. Of these, five cases were with subclinical hypothyroidism and the other 19 were euthyroid (data not shown). TPO-Ab were negative in all control subjects with statistically significant difference between cases and controls (P < 0.001) [Table 3].
There were statistically significant differences among different subgroups of AA regarding TSH (P < 0.01), free T3 (P < 0.01) and free T4 levels (P < 0.05) [Table 4].
|Table 4: Statistical comparison between subgroups of alopecia areata regarding TSH, free T3 and free T4|
Click here to view
Statistically significant differences were found among AA subgroups regarding the levels of both Tg-Ab (P < 0.05) and TPO-Ab (P < 0.05)) [Table 4].
A significant positive correlation was found between Tg-Ab and the levels of TSH (P < 0.05), free T3 (P < 0.01), free T4 (P < 0.01) and TPO-Ab (P < 0.001) [Table 5].
|Table 5: Pearson linear correlation between Tg - Ab, TPO - Ab and other parameters in group (A)|
Click here to view
A significant positive correlation was found between TPO-Ab and the levels of TSH (P < 0.001), free T3 (P < 0.001) and free T4 (P < 0.01) [Table 5].
| Discussion|| |
Alopecia areata is a common cause of non-cicatricial alopecia that occurs in a patchy, confluent or diffuse pattern. It may occur as a single, self-limiting episode or may recur at varying intervals over many years. 
Despite its long history, our knowledge about it is actually limited.  The etiology of AA is not exactly known, however factors such as genetic predisposition, autoimmunity and stress have been suggested. 
The role of cell mediated immunity was suggested by some investigators due to the lymphocytic infiltrate surrounding the anagen hair follicles and often invading the outer root sheath. 
Humoral immunity was suggested to play a role in AA development. Hair follicle-specific IgG autoantibodies have been found in increased concentrations in the peripheral blood of AA affected individuals compared to ''normal'', non-affected humans. 
Kamada et al.,  suggested that the immunologic mechanism for the development of AA involves an abnormal accumulation of C3 and sometimes IgG and IgM in the hair follicles of affected regions, and decreased numbers and disturbed function of T lymphocytes.
In all autoimmune diseases, induction of self-reactive CD4 T-helper cells plays a significant role.  After induction, two pathogenic mechanisms become activated. The first and more important is cell-mediated immune responses and the second is antibody-mediated immune responses. In AA and autoimmune thyroid dysfunction, both mechanisms play some role but like many more autoimmune diseases, the primary changes are due to T-cell-mediated immunity. 
Alopecia areata frequently occurs in association with other autoimmune disorders such as generalized vitiligo, lichen planus, morphea, lichen sclerosus et atrophicus, pemphigus foliaceus, atopic dermatitis, Hashimoto's thyroiditis, hypothyroidism, endemic goiter, Addison's disease, pernicious anemia, lupus erythematosus, diabetes mellitus, Down's syndrome and others. 
The aim of this work was to determine whether AA is associated with thyroid autoimmunity or thyroid function abnormalities in Egyptian patients.
In the current study, hypothyrodism was found in eight patients (16%) with significant differences between cases and controls regarding levels of TSH, free T3 and free T4.
Similarily, Kakourou et al.,  reported that in evaluation of 157 patients with AA, there were 5% of patients with concomitant AA and thyroid disorder. Those have had subclinical hypothyroidism of autoimmune aetiology that was revealed at the time of investigation.
Our results were also in agreement with a clinical study done by Thomas and Kadyan  who reported that among the thyroid disorders, hypothyroidism was the most frequent form of thyroid function abnormalities associated with AA. Also, Kasumagić-Halilović detected that thyroid functional abnormalities in the form of hypothyrodism were found in 11.4% of AA patients. Thomas and Kadyan  reported that hypothyroidism was evident in 14.1% of their studied AA population. Seyrafi et al.,  found thyroid function abnormalities in form of hypothyroidism in 8.9% of the studied AA cases. Similar findings were reported in previous studies. ,,
Conversely, Puavilai et al.,  reported that the prevalence of thyroid disease in patients with AA was relatively low (7.2%) with non-significant difference between patients and controls.
Although the effects of hypothyroidism on hair have long been known but the mechanism of such effects has not been elucidated.  The effects of hypothyroidism on hair include changes in hair texture and scalp alopecia. These can be explained by delayed or failure of resumption of anagen hair due to decreased metabolic rate which leads to loss of hair without replacement as well as increased telogen hair counts (club hair) before shedding.  Not all patients with hypothyroidism have alopecia; thus, it is likely that the magnitude of effect of thyroid hormone on hair growth is variable and its expression may be conditioned by local factors and other hormonal influences. 
So patients with AA should be screened for thyroid functional abnormalities even in absence of manifestations of hypothyroidism. Some investigators  recommended the assessment of thyroid gland size and function every six months as this will contribute to the early detection of autoimmune thyroiditis amongst patients with AA, preventing further evolution to severe hypothyroidism.
Subclinical hypothyroidism is diagnosed when levels of free T3 and free T4 are normal but serum TSH is above the reference range. 
In this study, there were statistically significant differences among different subgroups of AA regarding TSH, free T3 and free T4 levels. There was no comment on this observation on previous similar studies.
The current study showed that Tg-Ab were positive in 23 patients (46%) with AA. Tg-Ab were negative in all control subjects with significant difference between cases and controls.
These results were similar to the study done by Nanda et al.,  who reported a significant increase in serum Tg-Ab (14%) in children with AA. Kurtev and Ilev  stated that the presence of thyroid autoantibodies in AA patients was 39.5%.
These results were also consistent with a clinical study performed by Seyrafi et al.  They analyzed serum Tg-Ab level in patients with AA and found it to be elevated in 29.3% of their studied patients. Similarly, Korkij et al.,  detected Tg-Ab in 28% of AA cases.
TPO-Ab were positive in 24 patients (48%) with AA. TPO-Ab were negative in all control subjects with significant difference between cases and controls. Kasumagić-Halilović detected the frequency of thyroid autoantibodies (Tg-Ab and TPO-Ab) in AA to be 23.7% that was significantly higher when compared to healthy controls. Korkij et al.,  detected Tg-Ab in 28% of AA cases.
Syerafi et al.,  detected thyroid autoantibodies in 51% of cases. They explained this high ratio by racial and genetic effects. Grandolfo et al.,  stated that Tg-Ab and TPO-Ab are found more frequenly in patients with AA than healthy controls.
However, Cunliffe et al.,  and Puavilai et al.,  reported that there were non-significant differences between patients with AA and control subjects regarding the presence of Tg-Ab and TPO-Ab.
Tg-Ab and TPO-Ab were positive in 15 and 19 euthyroid patients respectively. It had been reported that Tg-Ab and TPO-Ab are frequently detectable in euthyroid individuals without functional thyroid abnormalities. , Prummel and Weirsinga  concluded that TPO-Ab is frequently present in euthyroid subjects, and there is impelling evidence that this constitutes a pre-clinical form of hypothyroidism, although they are also associated with a slightly raised risk for hyperthyroidism. Going with that, a number of large-scale studies have established a high prevalence of TPO-Ab in normal euthyroid subjects. , Vanderpump et al.,  concluded that the presence of TPO-Ab was strongly associated with thyroid failure during 20 years follow up of TPO-Ab positive euthyroid individuals. TPO-Ab correlated more clearly with altered thyroid functions than Tg-Ab. 
Therefore, determination of TPO-Ab status seems useful as first triage to select subjects out of a population in whom subsequent TSH testing and follow-up is clinically relevant. These include patients with family history of autoimmune thyroid disorders, patients with other autoimmune disorders and females before and during pregnancy.  Thyroid dysfunction is more common in women, and is of particular concern in women in reproductive age because abnormal maternal thyroid function during pregnancy has been associated with a wide variety of adverse maternal/fetal outcomes, including increased risk of pre-term birth, miscarriage, fetal death, impaired neuro-psychological development of the child  as well as maternal post-partum thyroiditis. 
Taken together, thyroid antibodies are means to identify a certain number of subjects whose thyroid function is completely normal but are at risk of thyroid dysfunction. So it's of particular importance to follow up euthyroid patients with AA and positive thyroid antibodies. These subjects do not require any treatment  but need to be followed up by TSH assay and morphological evaluation of the thyroid gland by ultrasonography to demonstrate an ongoing autoimmune thyroiditis even before modifications of thyroid function. 
In the current study, there were statistically significant differences among different subgroups of AA regarding the presence of Tg-Ab and TPO-Ab. There was no comment on this topic in previous similar studies.
The significant positive correlation between both Tg-Ab and TPO-Ab and levels of TSH, free T3 and free T4, detected in the present work, were not previously reported.
Thomas and Kadyan  explained the association between AA and thyroid autoimmunity by the formation of organ specific autoantibodies that play a pathogenic role in both disorders.
It has been suggested that the antigens in normal hair follicles are normally hidden from recognition by the immune cells. The immune cells need the help of major histocompatibility complex (MHC) proteins, which present antigens to immune cells. Therefore, in normal hair follicles, where there is normally no or very low, MHC expression, the antigens are ignored. But MHC proteins could be induced in hair follicles by physical trauma and/or the MHC antigens may be "abnormally good" at presenting hair follicle antigens. Once the hair follicles express MHC proteins, the immune cells can recognize antigens unique to the hair follicle so they go to work to get rid of them and in doing so, stop hair production. 
Kurtiv and Lliev  assumed that, the histologic studies have shown CD3+HLA-DR+lymphocytic infiltration in the epithelial cells of hair follicles, epidermal keratinocytes, and thyrocytes. These activated T lymphocytes play a role in the pathogenesis of AA and autoimmune thyroid dysfunction, as the aberrant HLA-DR antigen statement on the surface of the epithelial cells is realized through HLA-DR T lymphocytes. The increased number of activated T lymphocytes in the peripheral blood of patients with AA and autoimmune thyroid dysfunction, points not only to the participation of these lymphocytes in the pathogenesis of these diseases, but also to their inter-relationship.
| Conclusions|| |
From this work we can support the idea of association between thyroid abnormalities and AA. So, patients with AA should be screened for thyroid functions and thyroid autoimmunity even in absence of clinical manifestations of thyroid dysfunction for early detection of subclinical thyroid abnormalities.
| References|| |
|1.||Kasumagiæ-Haliloviæ E. Thyroid autoimmunity in patients with alopecia areata. Acta Dermatovenerol Croat 2008;16:123-5. |
|2.||Gilhar A, Ullmann Y, Berkutzki T, Assay B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-7. |
|3.||Dilas LT, Icin T, Paro JN, Bajkin I. Autoimmune thyroid disease and other non-endocrine autoimmune diseases. Med Pregl 2011;64:183-7. |
|4.||McElwee KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, et al. Comparison of alopecia areata in human and non human mammalian species. J Immunopathol Mol Cell Biol 1998;66:90-107. |
|5.||Petukhova L, Cabral RM, Mackay-Wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata. What's new and how it will help our Patients. Dermatol Ther 2011;24:326-36. |
|6.||Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata review. Int J Dermatol 2007;46:121-31. |
|7.||Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994;33:632-3. |
|8.||Kavak A, Baykal C, Ozarmaðan G, Akar U. HLA in alopecia areata. Int J Dermatol 2000;39:589-92. |
|9.||Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997;82:771-6. |
|10.||Hay ID, Bayer MF. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991;37:2002-8. |
|11.||Baloch Z, Carayon P, Conte-Devolx B, Dermers LM, Feldt-Rasmussen U, Henry JF. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;3:126-36. |
|12.||Lindstedt G, Berg G, Jansson S. Clinical use of laboratory thyroid tests and investigations. J Int Fed Cli Chem 1994;6:136-41. |
|13.||Alain D. The Politics of Large Numbers: A History of Statistical Reasoning. Trans. Camille Naish. 2 nd ed. United States: Harvard University Press; 2004. |
|14.||Hordinsky M, Ericson M. Autoimmunity: Alpecia areata. J Invest Dermatol Sym Proc 2004;9:73-8. |
|15.||Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I. Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr Dermatol 2002;19:486-91. |
|16.||Hoffmann R, Happle R. Alopecia areata. Clinical aspects, etiology, pathogenesis. Hautarzt 1999;50:222-31. |
|17.||Manzoor S, Masood C. Alopecia areata in Kashmir: A study of 200 patients. Indian J Dermatol Venereol Leprol 2001;67:324-5. |
|18.||Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994:102:721-4. |
|19.||Kamada N, Hatamochi A, Shinkai H. Alopecia areata associated with myasthenia gravis and thymoma. A case of alopecia with marked improvement following thymectomy and high level prednisolone administration. J Dermatol 1997;24:769-72. |
|20.||Lesage S, Hartley SB, Akkaraju S, Wilson J, Townsend M, Goodnow CC. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002;196:1175-88. |
|21.||Shahmoradi Z, Darougheh A, Misaghian S. Case Report. Association of Alopecia Universalis, Generalized Vitiligo, and Graves' Disease. J Res Med Sci 2005;10:224-5. |
|22.||Kakourou T, Karachristou K, Chrousos G. A case series of alopecia areata in children: Impact of personal and family history, stress and autoimmunity. J Eur Acad Dermatol Venereol 2006;21:356-9. |
|23.||Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: A clinical study. Ind J Dermatol 2008;53:70-4. |
|24.||Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A. Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 2005;31:5-11. |
|25.||Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol 1987;17:57-61. |
|26.||Lewinski A, Broniarczyk-Dyla G, Sewerynek E, Zerek-Melen G, Szkudlinski M. Abnormalities in structure and function of the thyroid gland in patients with alopecia areata. J Am Acad Dermatol 1990;23:768-9. |
|27.||Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055-60. |
|28.||Freinkel RK. Hair growth and alopecia in hypothyroidism. Arch Dermatol 1972;106:349-52. |
|29.||Sehgal VN. Vitiligo and alopecia areata associated with subclinical/clinical hypothyroidism. Skinmed 2011;9:192-4. |
|30.||Kurtev A, Ilev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol 2005;44:457-61. |
|31.||Korkij W, Soltani K, Simjee S, Marcincin PG, Chuang TY. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: A retrospective study. J Cutan Pathol 1984;11:522-30. |
|32.||Grandolfo M, Biscazzi AM, Pipoli M. Alopecia areata and autoimmunity. G Ital Dermatol Venereol 2008;143:277-81. |
|33.||Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969;81:877-81. |
|34.||Loviselli A, Velluzzi F, Mossa P, Cambosu MA, Secci G, Atzeni F, et al. The Sardinian Autoimmunity Study: 3. Studies on circulating antithyroid antibodies in Sardinian school children: relationship to goiter prevalence and thyroid function. Thyroid 2001;11:849-57. |
|35.||Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43:55-68. |
|36.||Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab 2005;19:1-15. |
|37.||Zophel K, Saller B, Wunderlich G, Grüning T, Koch R, Wilde J, et al. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: Implications for the definition of TPOAb reference intervals. Clin Lab 2003;49:591-600. |
|38.||Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000;143:639-47. |
|39.||Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-52. |
|40.||Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: Recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001;22:605-30. |
|41.||Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126. |
|42.||Pedersen IB, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L, et al. A population study of association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol 2005;62:713-20. |
|43.||Paus R. Immunology of the hair follicle. In: Bos JD, editor. Skin immune system. 2 nd ed. Philadelphia: Boca Raton, CRC Press; 1997. p. 377-98. |
What is new?
1. Thyroid autoantibodies may be detected in euthyroid AA subjects. These should be followed up for early detection of thyroid dysfunction
2. There is significant positive correlation between thyroid antibodies and levels of TSH, free T3 and free T4.
3. Levels of TSH are significantly higher, and free T3 and free T4 are significantly lower in severe AA compared with mild and moderate cases.
4. Levels of TPO-Ab and Tg-Ab are significantly higher in severe AA compared with mild and moderate cases.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
|This article has been cited by|
||EVALUATION OF THYROID PROFILE IN THE INDIAN POPULATION WITH ALOPECIA AREATA
| ||Krishna Chaitanya Paleti, Payasvi Sachdeva |
| ||GLOBAL JOURNAL FOR RESEARCH ANALYSIS. 2022; : 20 |
|[Pubmed] | [DOI]|
||Cross talk between oxidative stress and inflammation in alopecia areata
| ||Amany Ibrahim Mustafa, Rana Atef Khashaba, Eman Fawzy, Shimaa Mohamad AbdElRahman Baghdady, Shymaa Mostafa Rezk |
| ||Journal of Cosmetic Dermatology. 2021; 20(7): 2305 |
|[Pubmed] | [DOI]|
||Bidirectional association between alopecia areata and thyroid diseases: a nationwide population-based cohort study
| ||Ying-Xiu Dai, Ying-Hsuan Tai, Yun-Ting Chang, Tzeng-Ji Chen, Mu-Hong Chen |
| ||Archives of Dermatological Research. 2021; 313(5): 339 |
|[Pubmed] | [DOI]|
||Association between alopecia areata and thyroid dysfunction
| ||Piyu Parth Naik, Syed Nadir Farrukh |
| ||Postgraduate Medicine. 2021; : 1 |
|[Pubmed] | [DOI]|
||Identification and verification of EOMEs regulated network in Alopecia areata
| ||Xin Yuan, Yan Tang, Zhixiang Zhao, Fangfen Liu, Wei Shi, Yiya Zhang, Ji Li |
| ||International Immunopharmacology. 2020; 84: 106544 |
|[Pubmed] | [DOI]|
||Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
| ||Caihong Xin, Xin Sun, Li Lu, Rong Yang, Ling Shan, Yang Wang |
| ||Dermatology. 2020; 236(3): 251 |
|[Pubmed] | [DOI]|
||Thyroid function testing in primary care: overused and under-evidenced? A study examining which clinical features correspond to an abnormal thyroid function result
| ||A. Werhun,W. Hamilton |
| ||Family Practice. 2015; 32(2): 187 |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||5106 |
| Printed||111 |
| Emailed||2 |
| PDF Downloaded||105 |
| Comments ||[Add] |
| Cited by others ||7 |